Hepacivirus/drug effectsRefine your research by the most used items
Author / Editor
- Negro, Francesco (3)
- ANRS CO20-CUPIC study group (1)
- Allam, S (1)
- Boursier, J (1)
- Bronowicki, J-P (1)
- Bruggmann, P. (1)
- Canva, V (1)
- Clavien, P-A (1)
- De Lédinghen, V (1)
- Dinges, S. (1)
Document type
Full text accessibility
Full text version
Subject
Highlights
Show items per page
remove all| Title | Authors / Editors | Date | |
|---|---|---|---|
 |
Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes | Testoni, Barbara; Durantel, David; Lebossé, Fanny; Fresquet, Judith; ... Zoulim, Fabien | 2016 |
|
|
The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients | Boursier, J; Ducancelle, A; Vergniol, J; Veillon, P; ... De Lédinghen, V | 2015 |
|
|
Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation | Dinges, S.; Morard, Isabelle; Heim, M.; Dufour, J-F; ... Negro, Francesco | 2009 |
|
|
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients | Bruggmann, P.; Falcato, L.; Dober, S.; Helbling, B.; ... Meili, D. | 2008 |
